NMTR Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 2.40%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $0.00

9 Meters Biopharma Insider Trading History Chart

9 Meters Biopharma Share Price & Price History

^$0.00

▼ -0.0001 (-100.00%)

As of 12/3/2025 01:00 AM ET

Days: 30 | 90 | 365

9 Meters Biopharma Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
4/21/2023	Bethany Sensenig	CFO	Sell	9,100	$1.21	$11,011.00	41,077

SEC Filings (Institutional Ownership Changes) for 9 Meters Biopharma (NASDAQ:NMTR)

22.34% of 9 Meters Biopharma stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

9 Meters Biopharma Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/9/2023	ODonnell Financial Services LLC	43,410	$55K	0.5%	-95.1%	0.335%
2/7/2023	Commonwealth Equity Services LLC	38,141	$48K	0.0%	-90.3%	0.295%
1/19/2023	Adviser Investments LLC	21,429	$49K	0.0%	-92.3%	0.165%
11/16/2022	Requisite Capital Management LLC	300,000	$65K	0.0%	N/A	2.317%
11/15/2022	Laurion Capital Management LP	4,558,200	$0.98M	0.0%	+0.1%	35.198%
11/14/2022	Ergoteles LLC	911,451	$0.20M	0.0%	-8.5%	7.036%
11/7/2022	Virtu Financial LLC	228,595	$49K	0.0%	+25.6%	1.765%
10/31/2022	Valeo Financial Advisors LLC	209,688	$45K	0.0%	+5.8%	1.619%
8/15/2022	Laurion Capital Management LP	4,553,084	$1.19M	0.0%	N/A	1.757%
8/8/2022	Curi Wealth Management LLC	2,072,771	$0.54M	0.1%	+17,757.9%	0.800%
8/8/2022	Y Intercept Hong Kong Ltd	184,315	$48K	0.0%	N/A	0.071%
7/19/2022	Commonwealth Equity Services LLC	290,402	$75K	0.0%	+38.0%	0.112%
7/14/2022	Adviser Investments LLC	286,248	$75K	0.0%	+24.0%	0.110%
5/11/2022	GSA Capital Partners LLP	419,858	$0.25M	0.0%	-15.3%	0.163%
5/4/2022	Adviser Investments LLC	230,888	$0.14M	0.0%	+261.0%	0.089%
5/4/2022	Commonwealth Equity Services LLC	210,402	$0.13M	0.0%	+22.3%	0.081%
2/16/2022	Ghost Tree Capital LLC	3,250,000	$3.18M	1.1%	+18.2%	1.271%
2/14/2022	Blair William & Co. IL	81,912	$80K	0.0%	+192.5%	0.032%
2/14/2022	GSA Capital Partners LLP	495,783	$0.49M	0.1%	+3,414.2%	0.194%
2/9/2022	Principal Financial Group Inc.	68,709	$67K	0.0%	-23.0%	0.027%
2/8/2022	ProShare Advisors LLC	49,462	$48K	0.0%	+72.8%	0.019%
2/8/2022	Northern Trust Corp	2,136,520	$2.09M	0.0%	+2.1%	0.836%
2/7/2022	SG Americas Securities LLC	57,608	$56K	0.0%	-46.6%	0.023%
1/31/2022	Commonwealth Equity Services LLC	172,102	$0.17M	0.0%	+12.4%	0.067%
1/31/2022	Adviser Investments LLC	63,955	$63K	0.0%	N/A	0.025%
1/25/2022	J.W. Cole Advisors Inc.	45,000	$44K	0.0%	+50.0%	0.018%
11/16/2021	Schonfeld Strategic Advisors LLC	39,300	$51K	0.0%	N/A	0.015%
11/16/2021	Captrust Financial Advisors	29,844	$39K	0.0%	-74.8%	0.012%
11/16/2021	Two Sigma Securities LLC	24,834	$32K	0.0%	N/A	0.010%
11/16/2021	Metropolitan Life Insurance Co NY	64,133	$83K	0.0%	N/A	0.025%
11/12/2021	Geode Capital Management LLC	3,624,058	$4.71M	0.0%	+7.4%	1.423%
11/10/2021	Mercer Global Advisors Inc. ADV	60,000	$78K	0.0%	N/A	0.024%
11/10/2021	Panagora Asset Management Inc.	315,867	$0.41M	0.0%	N/A	0.124%
11/10/2021	Prentice Wealth Management LLC	29,000	$38K	0.0%	+59.3%	0.011%
11/10/2021	Citigroup Inc.	27,474	$36K	0.0%	+78.3%	0.011%
11/9/2021	BlackRock Inc.	13,566,265	$17.64M	0.0%	+0.6%	5.325%
11/9/2021	Boston Private Wealth LLC	26,000	$34K	0.0%	N/A	0.010%
11/8/2021	State Board of Administration of Florida Retirement System	52,330	$68K	0.0%	N/A	0.021%
11/5/2021	Advisor Group Holdings Inc.	62,547	$81K	0.0%	+84.0%	0.025%
11/4/2021	Almanack Investment Partners LLC.	40,850	$53K	0.0%	-21.7%	0.016%
11/4/2021	Deutsche Bank AG	1,078,613	$1.40M	0.0%	-65.9%	0.423%
11/2/2021	New York State Common Retirement Fund	103,586	$0.14M	0.0%	-43.1%	0.041%
11/1/2021	SG Americas Securities LLC	107,970	$0.14M	0.0%	+292.0%	0.042%
10/29/2021	Commonwealth Equity Services LLC	153,052	$0.20M	0.0%	+101.4%	0.060%
10/29/2021	ODonnell Financial Services LLC	840,727	$1.09M	0.5%	N/A	0.330%

Data available starting January 2016

9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders in North America. Its lead product candidate is Vurolenatide, a long-acting injectable glucagon-like-peptide-1 that is in Phase 3 clinical trial to treat short bowel syndrome. The company is developing NM-136, a humanized monoclonal antibody for the treatment of obesity and obesity-related disorders; NM-102, a small molecule peptide to prevent antigens from trafficking into systemic circulation; and NM-003, a proprietary long-acting glucagon-like peptide-2 receptor agonist for prevention of acute graft versus host disease. Its partnered product is Larazotide, an 8-amino acid peptide, which is in Phase 2 clinical trial for treatment of multi-system inflammatory syndrome. The company has licensing agreements with Amunix, MHS Care Innovation LLC, Alba Therapeutics Corporation, and EBRIS. 9 Meters Biopharma, Inc. is headquartered in Raleigh, North Carolina. On July 17, 2023, 9 Meters Biopharma, Inc. filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the Eastern District of North Carolina.

Today's Range

Now: N/A

50 Day Range

MA: N/A

52 Week Range

Now: N/A

Volume

3,617 shs

Average Volume

315,915 shs

Market Capitalization

$1.04 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.36